Herfarth, Christian [Hrsg.]; Bartsch, Helmut [Hrsg.]; Universitäts-Gesellschaft <Heidelberg> [Hrsg.]: Heidelberger Jahrbücher: Gesundheit (Berlin , Heidelberg , New York, 50.2006 [erschienen] 2007)

126 Lars Fischer et al.

Begg CB, Cramer LD, Hoskins WJ et al. (1998) Impact of hospital volume on operative mortality
for major Cancer surgery. JAMA 280:1747-1776

Birkmeyer JD, Warshaw AL, Finlayson STG et al. (1999) Relationship between hospital volume
and late survival after pancreatoduodenectomy. Surgery 126:178-183

Friess H, Kleeff J, Fischer L, Muller M, Buchler MW (2003) Surgical Standard therapy for Cancer
of the pancreas. Chirurg 74:183-190

Hruban RH, Canto MI, Yeo CJ et al. (2001) Prevention of pancreatic Cancer and strategies for
management of familiär pancreatic Cancer. Dig Dis 19:76-84

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer
Statistics, 2005. CA Cancer J Clin 55(i):io-3o

Knaebel HP, Märten A, Schmidt J, Hoffmann K, Seiler C, Lindel K, Schmitz-Winnenthal H, Fritz
S, Herrmann T, Goldschmidt H, Mansmann U, Debus J, Diehl V, Buchler MW. Phase III trial
of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation
treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI:
study protocol. BMC Cancer (2005) 5:37

Li J, Kleeff J, Kayed H, Felix K, Penzel R, Buchler MW, Korc M, Friess H (2004) Glypican-i antisense
transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic Cancer cells.
Biochem Biophys Res Commun 320:1148-1155

Neoptolemos JP, Dünn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli
P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Buchler
MW (2001) European Study Group for Pancreatic Cancer. Adjuvant chemoradiotherapy
and chemotherapy in resectable pancreatic Cancer: a randomised controlled trial. Lancet
358:1576-1585

Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dünn JA, Hickey H, Beger H, Fernandez-Cruz L,
Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Buchler MW (2004)
European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and
chemotherapy after resection of pancreatic Cancer. N Engl J Med. 35o(i2):i20o-i2io

Parkin DM, Muir CS, Whelan SL et al. (1992) Cancer incidence in 5 continents. Volume VI. Lyon:
International Agency for Research on Cancer (IARC Scientific Publication No. 120). Oxford
University Press

Picozzi VJ, Kozarek, RA, Traverso LW (2003) Interferon-based adjuvant chemoradiation therapy
after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 185:476-480

Seiler CA, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W, Friess H, Büchler MW (2005)
Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical
Whipple resection - long term results. Br J Surg 92:547-556

Sperti C, Pasquali C, Piccoli A et al. (1996) Survival after resection for ductal adenocarcinoma of
the pancreas. Br J Surg 83:625-631

Tsao JI, Rossi RL, Lowell JA (1994) Pylorus-preserving pancreatoduodenectomy. Arch Surg
129:405-412

van Berge MI, van Gulik TM, DeWit LT et al. (1997) Delayed gastric emptying after Standard pan-
creaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: An analysis
of 200 consecutive patients. J Am Coli Surg 185:373-379

Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW (2004) Curative resection is the
Single most important factor determining outcome in patients with pancreatic adenocarci-
noma. Br J Surg 91:586-594

Heidelberger Jahrbücher, Band 50 (2006)

C. Herfarth (Hrsg.) Gesundheit

© Springer-Verlag Berlin Heidelberg 2007